October, 2025
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases
Oct 2, 2025, 14:10

Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases

Sina Rashedi, Postdoctoral Research Fellow at Brigham and Women’s Hospital, Harvard Medical School, reposted from Behnood Bikdeli on X:

”Thrilled to share our recent JACC Journals

State-of-the-Art Review on fibrinolytic therapies for different thromboembolic diseases

Grateful to the outstanding experts I had the privilege to learn from and collaborate with on this paper!”

Read the full article in JACC.

Article: Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions

Authors: Sina Rashedi, Hannah Leyva, Nada Hamade, Mariana B. Pfeferman, Luis Ortega-Paz, Parham Sadeghipour, Azita H. Talasaz, Michelle L. O’Donoghue, David Jimenez, Manuel Monrea, Christopher D. Anderson, Mitchell S.V. Elkind, Irene M. Lang, Jeffery I. Weitz, Samuel Z. Goldhaber, Raffaele De Caterina, Stavros V. Konstantinides, Gregory Piazza, Harlan M. Krumholz, Eugene Braunwald, and Behnood Bikdeli

Behnood Bikdeli, Cardiologist and Vascular medicine specialist at Brigham and Women’s Hospital and Harvard Medical School, shared on X:

”Fibrinolytic therapies for cardiovascular conditions :

In JACC Journals we show current use, RCT data on MI, PE, DVT, stroke, and future directions!”

Sina Rashedi on Fibrinolytic Therapies in Different Thromboembolic Diseases

Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.